Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2004

Nov 17, 2004

29831_dirs_2004-11-17_66c091f5-a9bb-4cf8-8c62-a32730a9273a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2004-11-15

Reporting Person: CANGIALOSI LORETTA V (Vice President, Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-11-16 Common Stock M 1500 $8.17 Acquired 79699 Direct
2004-11-16 Common Stock F 447 $27.42 Disposed 79252 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-11-16 Employee Stock Option (right to buy) $8.17 M 1500 Disposed 2005-08-23 Common Stock (1500) Direct
2004-11-15 Phantom Stock Units SSP $0.00 A 132 Acquired Common Stock (132) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5491 Indirect

Footnotes

F1: The option became exercisable in 5 equal annual installments beginning on August 24, 1996.

F2: Each unit represents one phantom share of common stock.

F3: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service.